Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.60%982.06B | -5.24%909.52B | 6.19%4.1T | 1.77%989.2B | 9.18%1.01T | 6.70%959.84B | 9.08%3.87T | 6.56%1.07T | 5.59%972B | 8.01%923.44B |
| Cost of revenue | -2.63%675.85B | -5.01%612.01B | 4.79%2.78T | -0.58%661.14B | 10.89%694.11B | 5.41%644.28B | 6.01%2.65T | 5.60%752.74B | 3.23%664.97B | 3.97%625.96B |
| Gross profit | -2.52%306.21B | -5.72%297.51B | 9.27%1.32T | 6.85%328.06B | 5.59%314.12B | 9.45%315.56B | 16.48%1.21T | 8.92%317.39B | 11.10%307.02B | 17.64%297.49B |
| Operating expense | 1.11%169.54B | -0.91%157.12B | 11.11%663.23B | 9.86%165.43B | 13.66%167.69B | 12.23%158.56B | 9.96%596.91B | 11.08%157.51B | 6.51%150.58B | 9.44%147.53B |
| Selling and administrative expenses | 1.07%168.55B | -0.94%157.5B | 8.99%658.86B | 6.88%164.33B | 13.95%166.77B | 12.36%159B | 10.82%604.53B | 13.10%162.93B | 7.58%153.76B | 8.82%146.35B |
| -General and administrative expense | 1.07%168.55B | -0.94%157.5B | 8.99%658.86B | 6.88%164.33B | 13.95%166.77B | 12.36%159B | 10.82%604.53B | 13.10%162.93B | 7.58%153.76B | 8.82%146.35B |
| Other operating expenses | 7.86%988M | 12.01%-381M | 157.30%4.37B | 134.46%1.1B | -22.37%916M | -103.29%-433M | -183.36%-7.63B | -139.58%-5.42B | -105.30%-3.18B | 279.42%1.18B |
| Operating profit | -6.67%136.67B | -10.57%140.39B | 7.48%659.16B | 3.96%162.64B | -2.35%146.43B | 6.78%156.99B | 23.60%613.3B | 6.87%159.88B | 15.92%156.45B | 27.00%149.96B |
| Net non-operating interest income (expenses) | 5.34%-7.46B | 21.91%-6.54B | 9.27%-30.27B | 15.33%-7.55B | 5.53%-7.88B | -12.12%-8.38B | -67.47%-33.36B | -37.33%-8.63B | -14.94%-8.92B | -142.25%-8.34B |
| Non-operating interest income | -18.94%5.79B | -11.25%6.24B | 29.22%27.33B | 16.26%6.67B | 51.96%7.14B | 56.74%7.03B | 69.83%21.15B | 47.86%6.22B | 77.56%5.74B | 69.31%4.7B |
| Non-operating interest expense | -11.81%13.25B | -17.05%12.79B | 5.67%57.59B | -2.96%14.22B | 15.19%15.02B | 28.86%15.41B | 68.38%54.51B | 41.56%14.85B | 33.35%14.66B | 109.69%13.04B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 66.75%-2.03B | -10.63%-6.11B | ||||||||
| Less:Impairment of capital assets | ---- | ---- | -66.75%2.03B | ---- | ---- | ---- | 10.63%6.11B | ---- | ---- | ---- |
| Other non-operating income (expenses) | 79.71%-2.12B | -232.28%-2.55B | -1,303.83%-22.02B | -5.06%-5.54B | -493.30%-10.44B | -77.61%1.93B | -67.74%1.83B | 120.80%245M | 65.19%-5.28B | -368.29%-1.76B |
| Income before tax | -0.80%127.09B | -12.79%131.3B | 5.07%604.84B | 5.12%149.54B | -8.40%128.11B | 1.60%150.54B | 20.83%575.66B | 6.42%145.39B | 26.96%142.25B | 21.31%139.85B |
| Income tax | 29.68%38.8B | -2.31%36.63B | -13.10%145.63B | 0.80%39.83B | -16.79%29.92B | -3.07%37.5B | 23.63%167.58B | 39.41%53.43B | 3.02%39.52B | 22.50%35.96B |
| Net income | -9.63%90.74B | -16.21%96.79B | 12.58%468.73B | 7.51%112.33B | -4.87%100.41B | 3.45%115.52B | 20.27%416.36B | -5.80%94.66B | 39.82%104.48B | 21.37%105.54B |
| Net income continuous operations | -9.63%90.74B | -16.21%96.79B | 12.58%468.73B | 7.51%112.33B | -4.87%100.41B | 3.45%115.52B | 20.27%416.36B | -5.80%94.66B | 39.82%104.48B | 21.37%105.54B |
| Noncontrolling interests | -25.95%6.23B | -3.20%5.6B | 26.99%29.12B | -30.73%3.99B | 55.16%8.41B | -7.37%5.78B | 15.93%22.93B | -8.30%5.5B | 7.04%5.76B | 11.91%5.42B |
| Net income attributable to the company | -8.14%84.51B | -16.90%91.19B | 11.74%439.61B | 9.74%108.34B | -8.12%91.99B | 4.09%109.74B | 20.54%393.43B | -5.64%89.16B | 42.36%98.72B | 21.93%100.12B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -8.14%84.51B | -16.90%91.19B | 11.74%439.61B | 9.74%108.34B | -8.12%91.99B | 4.09%109.74B | 20.54%393.43B | -5.64%89.16B | 42.36%98.72B | 21.93%100.12B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -6.65%92.69 | -14.94%99.08 | 13.82%473.44 | 12.50%117.4 | -6.22%99.29 | 4.48%116.48 | 20.49%415.96 | -5.67%94.25 | 42.32%104.36 | 21.90%105.87 |
| Diluted earnings per share | -6.65%92.69 | -14.93%99.08 | 13.82%473.42 | 12.50%117.39 | -6.21%99.29 | 4.48%116.47 | 20.50%415.93 | -5.68%94.24 | 42.32%104.35 | 21.90%105.86 |
| Dividend per share | 14.46%95 | 0 | 13.77%190 | 0 | 15.28%83 | 0 | 20.14%167 | 26.67%95 | 0 | 12.50%72 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |